Method for the preparation of sevoflurane
View Patent ↗A method for the preparation of (CF 3 ) 2 CHOCH 2 F (Sevoflurane) is presented, which comprises providing a mixture of (CF 3 ) 2 CHOCH 2 Cl, potassium fluoride, water, and a phase transfer catalyst and reacting the mixture to form (CF 3 ) 2 CHOCH 2 F.
1. A process for the preparation of (CF 3 ) 2 CHOCH 2 F (sevoflurane), said process comprising forming a reaction mixture of (CF 3 ) 2 CHOCH 2 Cl, potassium fluoride, water and a phase transfer catalyst, and without the presence of an organic co-solvent, wherein the phase transfer catalyst is selected from the group consisting of: quaternary ammonium salts, quaternary phosphonium salts, and crown ethers, such that sevoflurane is formed.
2. A process as in claim 1 , wherein less than 5 wt % of the (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel is hydrolyzed.
3. A process as in claim 1 , wherein greater than 50% of the molar amount of (CF 3 ) 2 CHOCH 2 Cl consumed in the reaction is converted to sevoflurane.
4. A process as in claim 1 , wherein the reaction mixture is heated to a temperature in the range of 60 ° C. to 100 ° C., the pressure is in the range of from about 0 psig to 105 psig, and the time is in the range of about 3 to 16 hours.
5. A process as in claim 1 , wherein the mixture further comprises hydrochloric acid, hydrofluoric acid, or another inorganic or organic acid at an amount in the range of 1 to 3% based upon the weight of (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel.
6. A process as in claim 1 , wherein the reaction mixture further comprises potassium bifluoride (KHF 2 ) or a potassium fluoride hydrate salt.
7. A process for the preparation of sevoflurane comprising combining, in a reaction vessel, components comprising (CF 3 ) 2 CHOCH 2 Cl, potassium fluoride, water, and a phase transfer catalyst, and without the presence of an organic co-solvent, wherein the phase transfer catalyst is selected from the group consisting of: quaternary ammonium salts, quaternary phosphonium salts, and crown ethers, to form a reaction mixture wherein the molar amount of potassium fluoride per mole of (CF 3 ) 2 CHOCH 2 Cl added is greater than 0.1:1, the phase transfer catalyst is present in amounts greater than 0.25% based upon the weight of the (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel, and the water is present in amounts such that the weight of potassium fluoride to the combined weight of potassium fluoride and water is greater than 25%; wherein sevoflurane is formed.
8. A process as in claim 7 , further comprising heating the reaction mixture to a temperature in the range of 60 ° C. to 100 ° C., wherein the pressure of the reaction is in the range of from about 0 psig to 105 psig.
9. A process as in claim 7 further comprising the step of separating sevoflurane out of the reaction mixture.
10. A process as in claim 8 further comprising the step of separating sevoflurane out of the reaction mixture.
11. A process as in claim 7 , wherein the molar amount of potassium fluoride is in the range of from 1:1 to 2:1 moles of potassium fluoride per mole of (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel, the amount of phase transfer catalyst is in the range of 1 to 5% based upon the weight of (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel, and the quantity of water is in the range of from 10 to 50% based upon the weight of (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel.
12. A process as in claim 7 , wherein the mixture further comprises hydrochloric acid, hydrofluoric acid, or another inorganic or organic acid at an amount in the range of 1 to 3% based upon the weight of (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel.
13. A process as in claim 7 , wherein the reaction mixture further comprises potassium bifluoride (KHF 2 ) or a potassium fluoride hydrate salt.
14. A process as in claim 7 , wherein less than 5 wt % of the (CF 3 ) 2 CHOCH 2 Cl charged to the reaction vessel is hydrolyzed and greater than 50% of the molar amount of (CF 3 ) 2 CHOCH 2 Cl consumed in the reaction is converted to sevoflurane.
15. A process as in claim 1 further comprising the step of separating the sevoflurane out of the reaction mixture.
16. The process of claim 1 wherein the quaternary ammonium salt is selected from the group consisting of: methyl tetrabutyl ammonium chloride, tricapryl methylammonium chloride, and benzyl triethyl ammonium chloride.
17. The process of claim 1 wherein the quaternary phosphonium salt is selected from the group consisting of: butyl triphenyl phosphonium chloride and methyl triphenyl phosphonium bromide.
18. The process of claim 1 wherein the crown ether is selected from the group consisting of: 18-crown-6 and dibenzo-18-crown-6.
19. The process of claim 7 wherein the quaternary ammonium salt is selected from the group consisting of: methyl tetrabutyl ammonium chloride, tricapryl methylammonium chloride, and benzyl triethyl ammonium chloride.
20. The process of claim 7 wherein the quaternary phosphonium salt is selected from the group consisting of: butyl triphenyl phosphonium chloride and methyl triphenyl phosphonium bromide.
21. The process of claim 7 wherein the crown ether is selected from the group consisting of: 18-crown-6 and dibenzo-18-crown-6.